Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.

Autor: Dhir A; Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida., Hayashi M; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders Children's Hospital Colorado, Aurora, Colorado., Bodlak A; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders Children's Hospital Colorado, Aurora, Colorado., Oesterheld J; Cancer and Blood Disorders Program, Atrium Health Levine Children's Hospital, Charlotte, North Carolina., Loeb DM; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York.; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York., Mascarenhas L; Cedar-Sinai Medical Center, Guerin Children's and Cedar-Sinai Cancer, Los Angeles, California., Isakoff MS; Division of Hematology/Oncology, Connecticut Children's Medical Center, Hartford, Connecticut., Sandler ES; Division of Hematology/Oncology, Nemours Children's Health, Jacksonville, Florida., Borinstein SC; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Trucco M; Department of Pediatric Hematology-Oncology and BMT, Cleveland Clinic Children's, Cleveland, Ohio., Lagmay JP; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Shands Childrens Hospital, University of Florida, Gainesville, Florida., Setty BA; Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio., Pratilas CA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Caywood E; Division of Hematology/Oncology, Nemours Children's Health, Jacksonville, Florida., Metts J; Sarcoma Department, Moffitt Cancer Center, Tampa, Florida.; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Peterburg, Florida., Yin H; Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia., Fridley B; Health Services and Outcomes Research, Children's Mercy Hospital, Kansas City, Missouri., Yin J; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida., Laborde J; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida., Reed DR; Moffitt Cancer Center, Department of Individualized Cancer Management, Tampa, Florida., Adams DL; Creatv Microtech, Monmouth Junction, New Jersey., Wagner LM; Division of Pediatric Hematology/Oncology, Duke University, Durham, North Carolina.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 02; Vol. 30 (23), pp. 5314-5322.

Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy.

Autor: Iwase T; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; University of Hawai'i Cancer Center, 701 Ilalo Street Honolulu, HI 96813, USA., Parikh A; Diagnostic Radiology, Baylor College of Medicine, 1 Moursund St, Houston, TX 77030, USA., Wenli D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Shen Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Adams DL; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Tang CM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Cohen EN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Reuben JM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Shrimanker TV; Department of Internal Medicine, Greenwich Hospital, 5 Perryridge Rd Greenwich, CT 06830, USA., Chainitikun S; Department of Medical Oncology, MedPark Hospital, 3333 Rama IV Rd, Khlong Toei, Bangkok 10110, Thailand., Kida K; Breast Center, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan., Raghavendra AS; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Sapon ME; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Sahin O; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., James A; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Sridhar N; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Ueno NT; University of Hawai'i Cancer Center, 701 Ilalo Street Honolulu, HI 96813, USA.

Publikováno v: Journal of Cancer [J Cancer] 2024 Sep 16; Vol. 15 (18), pp. 5855-5862. Date of Electronic Publication: 2024 Sep 16 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Erratum to: Search for single top-quark production via flavour-changing neutral currents at 8 TeV with the ATLAS detector

Autor: Aad, G, Abbott, B, Abdallah, J, Abdinov, O, Aben, R, Abolins, M, AbouZeid, OS, Abramowicz, H, Abreu, H, Abreu, R, Abulaiti, Y, Acharya, BS, Adamczyk, L, Adams, DL, Adelman, J, Adomeit, S, Adye, T, Affolder, AA, Agatonovic-Jovin, T, Agricola, J, Aguilar-Saavedra, JA, Ahlen, SP, Ahmadov, F, Aielli, G, Akerstedt, H, Åkesson, TPA, Akimov, AV, Alberghi, GL, Albert, J, Albrand, S, Alconada Verzini, MJ, Aleksa, M, Aleksandrov, IN, Alexa, C, Alexander, G, Alexopoulos, T, Alhroob, M, Alimonti, G, Alio, L, Alison, J, Alkire, SP, Allbrooke, BMM, Allport, PP, Aloisio, A, Alonso, A, Alonso, F, Alpigiani, C, Altheimer, A, Alvarez Gonzalez, B, Álvarez Piqueras, D, Alviggi, MG, Amadio, BT, Amako, K, Amaral Coutinho, Y, Amelung, C, Amidei, D, Amor Dos Santos, SP, Amorim, A, Amoroso, S, Amram, N, Amundsen, G, Anastopoulos, C, Ancu, LS, Andari, N, Andeen, T, Anders, CF, Anders, G, Anders, JK, Anderson, KJ, Andreazza, A, Andrei, V, Angelidakis, S, Angelozzi, I, Anger, P, Angerami, A, Anghinolfi, F, Anisenkov, AV, Anjos, N, Annovi, A, Antonelli, M, Antonov, A, Antos, J, Anulli, F, Aoki, M, Aperio Bella, L, Arabidze, G, Arai, Y, Araque, JP, Arce, ATH, Arduh, FA, Arguin, J-F, Argyropoulos, S, Arik, M, Armbruster, AJ, Arnaez, O, Arnal, V, Arnold, H, Arratia, M, Arslan, O, Artamonov, A

Publikováno v: European Physical Journal C, vol 82, iss 1

One correction is noted for the paper. The branching fraction (Formula presented.) was not included in the conversion of the observed cross-section limit, (Formula presented.) to the coupling constants κugt and κcgt and the branching fractions B(t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::4479c87f1e3b93ce9b92c5b54ce6baa7
https://escholarship.org/uc/item/39q5605w

Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time.

Autor: Ali A; Creatv Bio, Division of Creatv MicroTech, Inc., 9 Deer Park Dr, Monmouth Junction, NJ, 08852, USA., Adams DL; Creatv Bio, Division of Creatv MicroTech, Inc., 9 Deer Park Dr, Monmouth Junction, NJ, 08852, USA. dan@creatvmicrotech.com., Kasabwala DM; Creatv Bio, Division of Creatv MicroTech, Inc., 9 Deer Park Dr, Monmouth Junction, NJ, 08852, USA., Tang CM; Creatv Bio, Division of Creatv MicroTech, Inc., 9900 Belward Campus Dr., Rockville, MD, 20850, USA., Ho TH; Division of Hematology/Oncology, Mayo Clinic Arizona, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, USA.

Publikováno v: Scientific reports [Sci Rep] 2023 Jun 29; Vol. 13 (1), pp. 10544. Date of Electronic Publication: 2023 Jun 29.